|
|
||||||||
RIIB Signaling in Resting and Activated B Cells1





*
Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206;
Department of Immunology, University of Colorado Health Science Center, Denver, CO 80206; and
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
| Abstract |
|---|
|
|
|---|
RIIB functions as an inhibitory receptor to dampen B cell Ag
receptor signals and immune responses. Accumulating evidence indicates
that ex vivo B cells require the inositol 5-phosphatase, Src homology
domain 2-containing inositol 5-phosphatase (SHIP), for
Fc
RIIB-mediated inhibitory signaling. However, we report here that
LPS-activated primary B cells do not require SHIP and thus differ from
resting B cells. SHIP-deficient B cell blasts display efficient
Fc
RIIB-dependent inhibition of calcium mobilization as well as Akt
and extracellular signal-related protein kinase phosphorylation.
Surprisingly, Fc
RIIB-dependent degradation of phosphatidylinositol
3,4,5-trisphosphate and conversion into phosphatidylinositol
3,4-bisphosphate occur in SHIP-deficient B cell blasts, demonstrating
the function of an additional inositol 5-phosphatase. Further analysis
reveals that while resting cells express only SHIP, B cell blasts also
express the recently described inositol 5-phosphatase, SHIP-2. Finally,
data suggest that both SHIP-2 and SHIP can mediate downstream biologic
consequences of Fc
RIIB signaling, including inhibition of the
proliferative response. | Introduction |
|---|
|
|
|---|
RIIB) coexpressed on B cells.
Coaggregation of the BCR with Fc
RIIB inhibits BCR signaling,
blocking downstream biologic responses including activation,
proliferation, and Ab production (1), and further serves
to reduce the development of autoimmune disease (2). The
initial event in inhibitory signaling is phosphorylation of the
immunoreceptor tyrosine-based inhibitory motif (ITIM) tyrosine found in
the Fc
RIIB cytoplasmic tail (3). This modification
results in recruitment of a limited number of Src homology 2 domain
(SH2)-containing phosphatases (4, 5), predominantly the
SH2 containing inositol 5-phosphatase (SHIP) (6, 7, 8).
Recruitment and activation of SHIP causes a dramatic and immediate
hydrolysis of the membrane lipid, phosphatidylinositol
3,4,5-trisphosphate (PI(3, 4, 5)P3), yielding
phosphatidylinositol 3,4-bisphosphate (PI(3, 4)P2)
(9, 10). PI(3, 4, 5)P3 is the
docking site for Pleckstrin homology domain containing proteins,
including Brutons tyrosine kinase, and phospholipase C
(PLC
)
(2, 11, 12). Therefore, SHIP-mediated hydrolysis of
PI(3, 4, 5)P3 leads to impaired membrane
translocation of these signal transducing molecules. Brutons tyrosine
kinase is required for activation of PLC
and hydrolysis of
phosphatidylinositol 4,5-bisphosphate yielding inositol
1,4,5-trisphosphate (Ins(1, 4, 5)P3) and
diacylglycerol. Thus SHIP inhibits the generation of second messengers
that mediate calcium mobilization and protein kinase C (PKC)
activation, respectively (13). Furthermore, activation of
mitogen-activated protein (MAP) kinases (14, 15) and the
recruitment of the antiapoptotic kinase, Akt (16, 17, 18), are
suppressed by Fc
RIIB coaggregation with the BCR, leading to
inhibition of cell proliferation and survival.
In addition to its catalytic activity, SHIP functions as an adaptor,
binding Shc (19, 20) and p62Dok
(14). Fc
RIIB binding to SHIP reportedly inhibits ras
activation (21, 22). In turn, impaired downstream
activation of the extracellular signal-related protein kinase (ERK)
family of MAP kinases and arrest of cell cycle progression and
proliferation occur. However, inhibition of ERK has also been
attributed to impaired PLC
-mediated activation of PKC
(23). Therefore, Fc
RIIB-mediated inhibition of ERK may
occur by at least two mechanisms; SHIP linkage to Shc or Dok, and SHIP
enzymatic degradation of PI(3, 4, 5)P3, preventing
activation of PKC.
The role of SHIP as a crucial regulator of cell signaling has been
conclusively demonstrated through studies of SHIP gene-ablated mice.
Although viable, these mice display a variety of abnormalities
including shortened life span, splenomegaly, increased B cell numbers,
elevated levels of basal serum Ab, and elevated Ab production upon
challenge with trinitrophenol-Ficoll (24, 25).
SHIP-/- B cells are characterized as
hypersensitive to both constitutive and Ag-induced signals
(26), displaying altered patterns of development,
increased survival, and increased activation (26, 27).
Strikingly, ex vivo B cells from these mice are insensitive to
Fc
RIIB-mediated inhibition of calcium mobilization, Akt and ERK
activation, and BCR-induced proliferation (25, 27).
Although these results suggest that SHIP is the sole mediator of
inhibitory signaling in primary B cells, other recent studies indicate
that the 5-phosphatase, SHIP-2, also binds to the phosphorylated
(p)-ITIM sequence in the cytoplasmic tail of Fc
RIIB (28, 29). Although not previously detected in primary B cells, SHIP-2
is highly expressed in nonhemopoietic cells (30, 31, 32) and
in select T and B cell lines (33, 34). SHIP-2 closely
resembles SHIP in both structure and enzymatic activity, but is the
product of a distinct gene (35). SHIP-2-deficient mice
display loss of negative regulation of insulin signaling and die
shortly after birth (36). Recent results have demonstrated
that enforced expression of SHIP-2 in phosphatidylinositol
3-phosphatase-deficient glioblastoma cells results in hydrolysis of
PI(3, 4, 5)P3, generating
PI(3, 4)P2 (37). In addition,
constitutive Akt activation is abolished, and cell cycle progression is
arrested in G1. These results demonstrate that
SHIP-2 is a potent negative regulator of
PI(3, 4, 5)P3-mediated signals.
In the studies presented here, we unexpectedly found that LPS-activated
B cells from SHIP-deficient mice exhibit significant
Fc
RIIB-mediated inhibition of calcium mobilization and
Ins(1, 4, 5)P3 production, as well as ERK and
Akt phosphorylation. This inhibition correlates with the expression of
SHIP-2 in activated, but not resting, primary B cells.
Fc
RIIB-dependent degradation of PI(3, 4, 5)P3
and conversion into PI(3, 4)P2 occur in
SHIP-deficient B cell blasts, thus supporting a role for SHIP-2
enzymatic activity. The observed degradation of
PI(3, 4, 5)P3 during Fc
RIIB signaling occurs
with a concomitant reduction in B cell proliferation, suggesting that
both SHIP and SHIP-2 can function in trans to block
proliferative signals generated by LPS activation. Therefore, Fc
RIIB
and its effectors, SHIP and SHIP-2, may play important roles in immune
complex-mediated termination of ongoing immune responses.
| Materials and Methods |
|---|
|
|
|---|
F(ab')2 and intact purified rabbit anti-mouse IgG and IgM (H+L) Abs were purchased from Zymed (South San Francisco, CA), and used for cell stimulation. Abs directed against the following molecules were used for immunoblot analysis. Polyclonal rabbit anti-Akt, p-Akt, ERK, and p-ERK were obtained from Cell Signaling. Polyclonal rabbit anti-SHIP was prepared as previously described (15) (NEB, Beverly, MA). Polyclonal rabbit anti-SHIP-2 was a generous gift from S. Swendemen and B. Clarkson (32). LPS (055:B5) and wortmannin were obtained from Sigma (St. Louis, MO).
Animals and cells
All animals used in this study were aged-matched 6- to 10-wk-old SHIP-/- mice and control SHIP+/+ littermates generated as the F1 progeny of SHIP+/- mice (24). Usually mice between 6 and 8 wk old were used to avoid the pathology associated with aged SHIP-/- mice. Splenic B cells were prepared as previously described (38). Briefly, spleens were excised from mice, cells were dispersed, and RBCs were lysed using Geys solution. Splenocytes were depleted of T cells by complement lysis using HO13.4 and T24 Abs, and B cells were further purified by discontinuous Percoll density gradient centrifugation (p > 1.07). For certain experiments, purified B cells were cultured with 25 µg/ml LPS in 20% FBS with 100 IU/ml penicillin and 100 µg/ml streptomycin for 48 h.
Calcium mobilization
For measurements of intracellular free calcium, 106 cells/ml in IMDM cells were loaded with Indo-AM (Molecular Probes, Eugene, OR) and stimulated with F(ab')2 or intact anti-IgM Ab. Mean intracellular free calcium was evaluated over time using a flow cytometer (model 50H; Ortho Diagnostic Systems, Raritan, NJ) with appended data acquisition system and MultiTime software (Phoenix Flow Systems, San Diego, CA) as previously described (38).
Measurement of PI(3, 4, 5)P3 and PI(3, 4)P2 generation
Splenic B cells from SHIP-/- or SHIP+/+ control littermates were depleted of RBCs and T cells and further purified by discontinuous Percoll density gradient centrifugation as described above. Cells were cultured for 48 h in 20% FBS as described above with the addition of 25 µg/ml LPS (incorporation of 32P label into the cellular ATP pool requires actively metabolizing cells). After 48 h in culture, cells were harvested, washed three times, and incubated for 90 min at 107 cells/ml in low phosphate medium with 0.5 mCi/ml [32P]orthophosphate. 32P-labeled cells were stimulated with F(ab')2 or intact anti-IgG for the indicated time and immediately lysed in 2.4 N HCl/methanol/chloroform (1:0.9:1.4 v/v). Lipids were extracted, deacylated with methanol/25% methylamine/n-butanol, and analyzed by HPLC on a SAX ion exchange column (Phenomenex, Torrance, CA) as previously described (26, 39).
Measurement of Ins(1, 4, 5)P3 generation
Ins(1, 4, 5)P3 generation was measured using a [3H] radioreceptor inhibition assay kit (DuPont-NEN, Boston, MA) according to the manufacturers instructions. Splenic B cells used in this study were cultured with LPS for 48 h as described above.
B cell stimulation and cell lysis
The cells were washed with IMDM three times and resuspended in
IMDM. After prewarming at 37°C for 10 min, cells were stimulated with
intact or F(ab')2 rabbit anti-mouse Ig (H +
L) for the period indicated. After stimulation, the cells were washed
three times with ice-cold PBS and lysed with solubilizing buffer (1%
Triton X-100, 10 mM Tris pH 7.5, 150 mM NaCl, 0.4 mM EDTA, 10 mM NaF, 2
mM Na3VO4, 1 µg/ml
leupeptin, 1 µg/ml aprotinin, 1 µg/ml
1-antitrypsin, and 1 mM PMSF), and cleared
supernatants were retained for further processing.
Immunoblotting analysis
Cleared cell lysates were separated by 10% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Millipore, Bedford, MA). After blocking, polyvinylidene difluoride membranes were blotted with the indicated Ab and detected using the ECL Western blotting system (Amersham, Little Chalfont, U.K.). In some cases, the membranes were stripped to remove the Ab and subject to sequential blotting with other Abs. The membranes were incubated with the anti-p-AKT, -Akt, -SHIP, -SHIP-2, -p44/p42 ERK, or -phospho-p44/p42 ERK Ab followed by incubation with HRP-conjugated protein A.
In vitro B cell proliferation
Freshly purified splenic B cells (1 x 105/100 µl) were cultured with 20 µg/ml LPS as described above. After 24 h of LPS stimulation, 40 µg/ml of intact or F(ab')2 anti-IgM Ab was added. After 172 h of LPS stimulation, cells were incubated with 1 uCi/well of [3H]thymidine (Amersham) and harvested 4 h after thymidine addition. Experiments were performed in triplicate wells.
| Results |
|---|
|
|
|---|
RIIB-mediated inhibition of calcium mobilization occurs
independently of SHIP in LPS-activated B cells
Fc
RIIB coaggregation with the BCR leads to inhibition of
Ins(1, 4, 5)P3 generation and calcium mobilization.
A significant role for SHIP in mediating inhibitory signals has been
shown through recent biochemical and genetic studies. Examination of ex
vivo B cells from SHIP-deficient mice revealed ablation of
Fc
RIIB-mediated inhibition of the calcium response
(25), leading to substantial increases in extracellular
calcium influx (Fig. 1
A).
Although ex vivo B cells from SHIP-deficient mice demonstrated
virtually complete ablation of the inhibitory response through
Fc
RIIB, a limited number of studies have indicated that signaling
may be altered in LPS-activated B cell blasts (40, 41). To
test the role of SHIP in these populations, B cells from SHIP-deficient
or wild-type littermates were activated with the mitogen, LPS, for
48 h. Calcium mobilization responses were monitored after
cross-linking the BCR with F(ab')2 of rabbit
anti-mouse Ig or with intact Ab to coaggregate Fc
RIIB with the
BCR. In marked contrast to resting B cells, LPS blasts derived from
SHIP-/- mice exhibited significant
Fc
RIIB-mediated inhibition of calcium influx and
Ins(1, 4, 5)P3 production (Fig. 1
, B and
C). Thus, partially distinct mechanisms must mediate
Fc
RIIB signaling in resting and activated B cells.
|
RIIB
coaggregation in SHIP-deficient B cell blasts
The inhibition of calcium mobilization and PLC
-induced
Ins(1, 4, 5)P3 generation observed in
SHIP-/- B cell blasts prompted us to examine
whether additional Fc
RIIB-mediated responses were similarly
attenuated. Fc
RIIB-mediated recruitment of SHIP leads to inhibition
of activation of the antiapoptotic enzyme Akt by preventing its
PI(3, 4, 5)P3-dependent translocation to the plasma
membrane (16, 18). Subsequent serine/threonine
phosphorylation is consequently reduced, resulting in attenuated Akt
activation. Consistent with studies by Helgason (27),
examination of Akt phosphorylation following Fc
RIIB coaggregation
with the BCR revealed inhibition in wild-type but not SHIP-deficient
resting primary B cells (Fig. 2
A). In contrast,
Fc
RIIB-mediated inhibition of BCR-induced Akt phosphorylation was
observed in both wild-type and SHIP-deficient B cell blasts (Fig. 2
B), particularly at later time points. Therefore, unlike
resting B cells, SHIP-/- B cell blasts retain
Fc
RIIB-mediated inhibition of Akt activation, supporting the
hypothesis that additional inhibitory signals function in activated B
cells.
|
RIIB
coaggregation in SHIP-deficient B cell blasts
Two possible mechanisms have been proposed to account for
SHIP-mediated inhibition of ERK activation following Fc
RIIB
coaggregation with the BCR. ERK inhibition could occur through
attenuation of PLC
-mediated PKC signaling (23).
Alternatively, ERK inhibition could occur through attenuation of ras
activation (21), because SHIP also mediates recruitment of
rasGAP via p62Dok
(14).
Previous reports (25, 27) and Fig. 3
A, demonstrate that SHIP
deficiency abolishes Fc
RIIB-mediated inhibition of ERK signaling in
ex vivo B cells. In contrast, LPS-activated B cells from
SHIP-/- mice display inhibition of ERK
phosphorylation (Fig. 3
B). It should be noted that the
kinetics of inhibition were delayed compared with resting splenocytes,
with at least 30 min required before a reduction in phosphorylation was
apparent. Fc
RIIB-mediated inhibition of ERK has been attributed to
phosphorylation and recruitment of p62Dok.
However, previous studies by Tamir et al. have demonstrated that
Fc
RIIB-induced phosphorylation of Dok is completely absent in
SHIP-deficient B cell blasts (14). Therefore, in activated
cells, Fc
RIIB-mediated inhibition of ERK occurs independently of
p62Dok phosphorylation, possibly through
attenuation of PKC activation.
|
RIIB coaggregation in SHIP-/- B cell blasts
Because calcium mobilization and phosphorylation of Akt and ERK
are dependent upon PI(3, 4, 5)P3 generation, we
next determined whether the Fc
RIIB-mediated inhibition of signaling
in SHIP-/- B cells reflected reduced
PI(3, 4, 5)P3 accumulation. To determine the
enzymatic activity of SHIP in B cell blasts, levels of
PI(3, 4, 5)P3 and its breakdown product,
PI(3, 4)P2, were measured by HPLC (26, 39, 42). B cell blasts generated from
SHIP-/- or control littermates were stimulated
with F(ab')2 of anti-BCR or intact Ab to
coaggregate Fc
RIIB with the BCR. Fig. 4
A shows that coaggregation of
the BCR and Fc
RIIB resulted in nearly total hydrolysis of
PI(3, 4, 5)P3 in wild-type cells. Approximately
99% of PI(3, 4, 5)P3 in wild-type cells was
degraded to PI(3, 4)P2 even at the earliest
measurable time point, 30 s. As previously described
(26), there are significant increases in
PI(3, 4, 5)P3 levels following BCR aggregation in
the SHIP-/- B cells, suggesting that SHIP may
negatively regulate signaling through the BCR. Surprisingly, enzymatic
degradation of PI(3, 4, 5)P3 and resultant
PI(3, 4)P2 formation were still apparent in the
SHIP-deficient B cell blasts (Fig. 4
B), suggesting the
action of an additional inositol 5-phosphatase. Therefore, multiple
pathways control the levels of PI(3, 4, 5)P3 in
activated B cells.
|
Because the above results demonstrate an additional inositol
5-phosphatase activity present and operative in
SHIP-/- B cell blasts, we were prompted to
assess SHIP-2 expression in these cells. SHIP-2 is widely expressed
(30), while SHIP is restricted to cells of hemopoietic
lineage (43). Although SHIP-2 has recently been shown to
become phosphorylated and associate with Fc
RIIB in the A20 B cell
line (28, 29), its expression in primary B cells has not
been observed. As shown in Fig. 5
, SHIP-2
was not detected in resting B cells, but expression was induced
following stimulation for 48 h with LPS. Equal levels of SHIP-2
were detected in both wild-type and SHIP-deficient LPS blasts. In
addition, levels of SHIP increased 10-fold following B cell activation.
In comparison, levels of total p42/44 ERK remained relatively constant
throughout activation. A time course analysis revealed that increases
in SHIP and SHIP-2 occur after 24 h of stimulation with LPS (data
not shown). Therefore, in resting cells, SHIP is likely to be the
primary mediator of inhibitory signaling, while in activated cells,
both SHIP and SHIP-2 contribute. Upon B cell activation, SHIP-2
apparently also contributes to the inhibition of calcium mobilization,
Ins(1, 4, 5)P3 generation, Akt/ERK phosphorylation,
as well as PI(3, 4, 5)P3 degradation, seen
following Fc
RIIB coaggregation with the BCR.
|
RIIB-mediated inhibition of proliferation
Coaggregation of Fc
RIIB inhibits downstream BCR-mediated cell
proliferation. Previous studies have shown that Fc
RIIB-mediated
inhibition of BCR-induced proliferation is completely ablated in ex
vivo B cells from SHIP-deficient mice (25, 27). To
determine whether Fc
RIIB can function to block proliferation of
activated B cells, ex vivo B cells were stimulated for 24 h with
LPS and then treated with F(ab')2 of anti-BCR
or with intact Ab to coaggregate Fc
RIIB with the BCR. As shown in
Fig. 6
, B cells continued to proliferate
following aggregation of the BCR; however, coaggregation of Fc
RIIB
resulted in attenuation of proliferation. Thus Fc
RIIB can function
in trans to inhibit proliferation stimulated by LPS
treatment. Interestingly, SHIP-/- B cell blasts
were also sensitive to Fc
RIIB-mediated inhibition of ongoing
proliferation, suggesting that the inhibition can be mediated by
SHIP-2. It is likely that Fc
RIIB-mediated inhibition is linked to
degradation of PI(3, 4, 5)P3, because the addition
of wortmannin had similar antiproliferative effects (Fig. 6
).
Therefore, in B cell blasts, SHIP- and SHIP-2-mediated degradation of
PI(3, 4, 5)P3 are likely to contribute to
Fc
RIIB-mediated inhibition of proliferation. It should be noted that
PLC
activation, calcium mobilization, Akt, PKC, and MAP kinase
activation all have been implicated as regulators of cell cycle
progression. Consequently, it remains to be determined which of these
PI(3, 4, 5)P3-regulated pathways, singly, or in
combination, contributes to inhibition of cell cycle progression
induced by Fc
RIIB coaggregation.
|
| Discussion |
|---|
|
|
|---|
RIIB inhibits
BCR-mediated signaling, resulting in a blockade of PLC
activation,
calcium mobilization, ERK and Akt phosphorylation, and downstream
blastogenesis (2, 8). Previous reports have shown that
resting ex vivo B cells from SHIP-deficient mice are insensitive to
Fc
RIIB-mediated inhibition (25, 27). In contrast, we
report that LPS-activated B cells from SHIP-deficient mice are
significantly inhibited by signals mediated through Fc
RIIB.
Surprisingly, SHIP-deficient LPS blasts display prominent
Fc
RIIB-mediated inhibition of calcium mobilization,
Ins(1, 4, 5)P3 production, as well as Akt and ERK
phosphorylation.
We attribute this inhibition to the expression of SHIP-2 in LPS B cell
blasts. Although not detectable in resting splenocytes, we find that
SHIP-2 is inducibly expressed upon B cell activation. Previous in vitro
analysis of SHIP-2 enzymatic activity has revealed that SHIP and SHIP-2
have similar functions (35). Furthermore, SHIP and SHIP-2
have partially homologous SH2 domains (30) and nearly
identical affinity for the p-ITIM in the cytoplasmic tail of Fc
RIIB
(29). Together, this suggests that the Fc
RIIB-mediated
degradation of PI(3, 4, 5)P3 observed in
SHIP-deficient B cell blasts is mediated by de novo expression of
SHIP-2. Concomitantly, Fc
RIIB expression is increased 10-fold upon
LPS stimulation (41). Therefore, in activated B cells, the
up-regulation of Fc
RIIB, SHIP, and SHIP-2 all may contribute to the
inhibition of phosphatidylinositol 3-kinase (PI3-K) signaling pathways
induced by immune complexes.
Although SHIP and SHIP-2 have similar phosphatase activities and
affinity for Fc
RIIB, their divergent amino acid sequences suggest
differing linker function. Both SHIP and SHIP-2 bind to the adapter
molecule, Shc (6, 32), but SHIP-2 selectively binds the
SH3 domain of abl, while SHIP binds the SH3 domain of src
(32). Surprisingly, SHIP-2, unlike SHIP, does not
associate with grb-2 (32). Examination of the C-terminal
domain of SHIP-2, a region essential for SHIP translocation and
function in vivo (44, 45, 46), reveals that SHIP-2 contains
only one NPXY motif (30). Furthermore, because Fc
RIIB
ligation in SHIP-/- blasts does not lead to
enhanced Dok phosphorylation, we suspect that Fc
RIIB coaggregation
does not induce an association between SHIP-2 and
p62Dok (14). This indicates that
SHIP and SHIP-2 associate with different sets of effectors, and thus
may have partially distinct function, in activated B cells.
SHIP and, more recently, SHIP-2 have been strongly implicated as
negative regulators in a variety of cell types. SHIP has demonstrated
activity as an inhibitor of cytokine and growth factor-induced
signaling in mast cells (47). Because mast cell
degranulation via Fc
RI (48) or steel factor receptor
(49) is significantly enhanced in SHIP-deficient bone
marrow-derived mast cells, SHIP has been described as the
"gatekeeper" for mast cell degranulation. Furthermore, SHIP has
been linked to inhibition of growth factor-mediated proliferation in
these cells (50). SHIP-2 also negatively regulates
signaling events induced by numerous growth factor receptors and
insulin (36). Consistent with the above studies, a recent
report has directly demonstrated that SHIP-2 expression in glioblastoma
cells suppresses growth responses (37).
Previous studies of T cells have shown a requirement for PI3-K for cell
proliferation, because PI(3, 4, 5)P3-mediated
activation of Akt is sufficient to induce E2F activity
(51). PI3-K is required for phosphorylation of Rb,
induction of cyclin D3, and degradation of
p27Kip1 (51). These results
establish a crucial link between PI3-K and the cell cycle machinery.
PI3-K-mediated activation of Akt also promotes cell survival signals
through NF-
phosphorylation and activation of the I
-
kinase (52). In addition, Akt phosphorylation inhibits the
proapoptotic activities of Bad (53) and caspase-9
(54). We find that activated B cells, like T cells, are
likely to have similar requirements for PI3-K activity, as wortmannin
significantly inhibits both B and T cell proliferation. Consistent with
studies presented here, T lymphocytes have been shown to increase
expression of SHIP-2 following activation (33). These
results suggest that induction of SHIP and/or SHIP-2 and subsequent
degradation of PI(3, 4, 5)P3, may be a common
mechanism used by hemopoietic cells to modulate the effects of
stimulation.
The above results support a model in which mitogenic stimulation of
quiescent B cells triggers PI(3, 4, 5)P3
generation, Akt activation, and cell cycle progression. Support for
this model comes from studies that demonstrate that the addition of
wortmannin inhibits this progression. In contrast, elevated basal
levels of PI(3, 4, 5)P3 can trigger unregulated
cell cycle progression, lymphocyte hyperproliferation, and autoimmunity
(55), indicating that PI(3, 4, 5)P3
normally limits these responses. Taken together with the fact that mice
deficient in SHIP or PTEN, a phosphatidylinositol 3-phosphatase tend
toward lymphocyte hyperproliferation, the precise regulation of
PI(3, 4, 5)P3 levels within the cell are of utmost
importance. We suggest that in normal cells, immune complex-induced
degradation of PI(3, 4, 5)P3 counterbalances the
effects of mitogenic stimulation and causes arrest of cell cycle
progression. This may explain the attenuating effects of Fc
RIIB late
in the immune response.
Intriguingly, we and others have found that Fc
RIIB-mediated
inhibition can function to block proliferative signals generated by LPS
or IL-4 stimulation (56), even in the absence of direct
coaggregation with these receptors. Thus, cross-talk between LPS- or
IL-4-mediated activating signals and Fc
RIIB-mediated inhibitory
signals must occur. In contrast, killer Ig-related receptors require
direct coassociation with the activating receptor to attenuate
signaling. This may reflect the fact that killer Ig-related receptors
tether SH2 domain-containing protein tyrosine
phosphatase, which can act in only a localized
area. In contrast, by efficiently reducing
PI(3, 4, 5)P3 levels cell-wide, SHIP can indirectly
inhibit signaling by all receptors that require
PI(3, 4, 5)P3 generation. Thus, the negative signal
transmitted upon B cell encounter with immune complexes likely inhibits
responses to many ligands.
Although activated or proliferating B cell blasts may represent an
important target of immune complex-mediated inhibition of the immune
response, elucidation of the inhibitory signaling mechanisms operative
in this B cell subset is only beginning. Activated B cells differ from
resting B cells in their significantly elevated levels of SHIP, SHIP-2,
and Fc
RIIB. Thus, these cells may be more sensitive to negative
feedback regulation by immune complexes.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. John C. Cambier, Integrated Department of Immunology, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206. E-mail address: cambierj{at}njc.org ![]()
3 Abbreviations used in this paper: BCR, B cell Ag receptor; PI3-K, phosphatidylinositol 3-kinase; ERK, extracellular signal-related protein kinase; ITIM, immunoreceptor tyrosine-based inhibitory motif; SH2, Src homology domain 2; SHIP, SH2 containing inositol 5-phosphatase; PI(3,4,5)P3, phosphatidylinositol 3,4,5-trisphosphate; PI(3,4)P2, phosphatidylinositol 3,4,-bisphosphate; PLC
, phospholipase C
; Ins(1,4,5)P3, inositol 1,4,5-trisphosphate; PKC, protein kinase C; MAP, mitogen-activated protein; p, phosphorylated. ![]()
Received for publication January 24, 2001. Accepted for publication April 27, 2001.
| References |
|---|
|
|
|---|
RIIb. Curr. Opin. Immunol. 10:306.[Medline]
RIIB modulates B-cell receptor signalling. Nature 368:70.[Medline]
RIIB1. Science 268:293.
RIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1. J. Immunol. 161:2716.
RIIB. Nature 383:263.[Medline]
receptor IIB that function in inhibitory signaling. J. Immunol. 165:4453.
by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 17:414.[Medline]
RIIB signals in B cells. Immunity 12:347.[Medline]
RIIB1-effector interactions and inhibitory functions. J. Immunol. 164:631.
RIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells. J. Biol. Chem. 274:13704.
immunoreceptor tyrosine-based inhibition motif peptide motif. Mol. Cell Biol. 17:4305.[Abstract]
2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J. Exp. Med. 188:1287.
RIIB in B cells under negative signaling. Immunol. Lett. 72:7.[Medline]
RIIB. J. Biol. Chem. 275:37357.
RII expression in resting and activated B lymphocytes. Eur. J. Immunol. 19:1379.[Medline]
RIIb1-mediated inhibition of B cell receptor signaling. J. Biol. Chem. 274:7489.
RIIB1-mediated inhibitory signaling. Mol. Cell Biol. 20:3576.
) isoform can substitute for p145 SHIP in Fc
RIIB1-mediated inhibitory signaling in B cells. J. Biol. Chem. 275:29960.
RIIB. J. Immunol. 162:4424.
B by the Akt/PKB kinase. Curr. Biol. 9:601.[Medline]
RIIB-induced B cell apoptosis. Immunity 10:753.[Medline]
This article has been cited by other articles:
![]() |
Z. S. M. Rahman and T. Manser Failed Up-Regulation of the Inhibitory IgG Fc Receptor Fc{gamma}RIIB on Germinal Center B Cells in Autoimmune-Prone Mice Is Not Associated with Deletion Polymorphisms in the Promoter Region of the Fc{gamma}RIIB Gene J. Immunol., August 1, 2005; 175(3): 1440 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vedham, H. Phee, and K. M. Coggeshall Vav Activation and Function as a Rac Guanine Nucleotide Exchange Factor in Macrophage Colony-Stimulating Factor-Induced Macrophage Chemotaxis Mol. Cell. Biol., May 15, 2005; 25(10): 4211 - 4220. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Isnardi, R. Lesourne, P. Bruhns, W. H. Fridman, J. C. Cambier, and M. Daeron Two Distinct Tyrosine-based Motifs Enable the Inhibitory Receptor Fc{gamma}RIIB to Cooperatively Recruit the Inositol Phosphatases SHIP1/2 and the Adapters Grb2/Grap J. Biol. Chem., December 10, 2004; 279(50): 51931 - 51938. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, R. J. Keogh, M. G. Hunter, C. A. Mitchell, R. S. Frey, K. Javaid, A. B. Malik, S. Schurmans, S. Tridandapani, and C. B. Marsh SHIP2 Is Recruited to the Cell Membrane upon Macrophage Colony-Stimulating Factor (M-CSF) Stimulation and Regulates M-CSF-Induced Signaling J. Immunol., December 1, 2004; 173(11): 6820 - 6830. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Pengal, L. P. Ganesan, H. Fang, C. B. Marsh, C. L. Anderson, and S. Tridandapani SHIP-2 Inositol Phosphatase Is Inducibly Expressed in Human Monocytes and Serves to Regulate Fc{gamma} Receptor-mediated Signaling J. Biol. Chem., June 13, 2003; 278(25): 22657 - 22663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Rao, K. A. Vora, and T. Manser Differential Expression of the Inhibitory IgG Fc Receptor Fc{gamma}RIIB on Germinal Center Cells: Implications for Selection of High-Affinity B Cells J. Immunol., August 15, 2002; 169(4): 1859 - 1868. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||